Dhampure Speciality Sugars Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 12:25 am

Quick Insight

Dhampure Speciality Sugars Ltd, with a share price of 91.2 and a market cap of 76.0 Cr., presents a P/E ratio of 24.6 and ROE of 8.88%, indicating moderate profitability. The company's ROCE stands at 11.6%, reflecting efficient capital utilization. With an OPM of 10.93% and a healthy ICR of 431.14x, Dhampure shows operational stability and strong debt-servicing capability. Despite a P/BV of 2.43x, suggesting some premium valuation, the company's solid reserves of 25.80 Cr. and zero borrowings provide a robust financial base. Overall, Dhampure's financial health appears sound, offering potential for growth and shareholder value creation in the sugar industry.

Competitors of Dhampure Speciality Sugars Ltd

All Competitor Stocks of Dhampure Speciality Sugars Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:10 pm

Below is a detailed analysis of the quarterly data for Dhampure Speciality Sugars Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 9.97 Cr.. The value appears to be declining and may need further review. It has decreased from 12.94 Cr. (Mar 2025) to 9.97 Cr., marking a decrease of 2.97 Cr..
• For Expenses, as of Jun 2025, the value is 8.88 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.67 Cr. (Mar 2025) to 8.88 Cr., marking a decrease of 3.79 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.27 Cr. (Mar 2025) to 1.09 Cr., marking an increase of 0.82 Cr..
• For OPM %, as of Jun 2025, the value is 10.93%. The value appears strong and on an upward trend. It has increased from 2.09% (Mar 2025) to 10.93%, marking an increase of 8.84%.
• For Other Income, as of Jun 2025, the value is 0.29 Cr.. The value appears strong and on an upward trend. It has increased from -0.03 Cr. (Mar 2025) to 0.29 Cr., marking an increase of 0.32 Cr..
• For Interest, as of Jun 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -0.33 Cr. (Mar 2025) to 0.10 Cr., marking an increase of 0.43 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.27 Cr.. The value appears strong and on an upward trend. It has increased from 0.57 Cr. (Mar 2025) to 1.27 Cr., marking an increase of 0.70 Cr..
• For Tax %, as of Jun 2025, the value is 24.41%. The value appears to be increasing, which may not be favorable. It has increased from 14.04% (Mar 2025) to 24.41%, marking an increase of 10.37%.
• For Net Profit, as of Jun 2025, the value is 0.97 Cr.. The value appears strong and on an upward trend. It has increased from 0.49 Cr. (Mar 2025) to 0.97 Cr., marking an increase of 0.48 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.16. The value appears strong and on an upward trend. It has increased from 0.59 (Mar 2025) to 1.16, marking an increase of 0.57.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:53 pm

Growth

Last Updated: September 5, 2025, 3:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:27 pm

Below is a detailed analysis of the balance sheet data for Dhampure Speciality Sugars Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 8.33 Cr.. The value appears strong and on an upward trend. It has increased from 7.93 Cr. (Mar 2024) to 8.33 Cr., marking an increase of 0.40 Cr..
• For Reserves, as of Mar 2025, the value is 25.80 Cr.. The value appears strong and on an upward trend. It has increased from 18.74 Cr. (Mar 2024) to 25.80 Cr., marking an increase of 7.06 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 5.61 Cr.. The value appears to be improving (decreasing). It has decreased from 9.35 Cr. (Mar 2024) to 5.61 Cr., marking a decrease of 3.74 Cr..
• For Total Liabilities, as of Mar 2025, the value is 39.74 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.02 Cr. (Mar 2024) to 39.74 Cr., marking an increase of 3.72 Cr..
• For Fixed Assets, as of Mar 2025, the value is 21.81 Cr.. The value appears strong and on an upward trend. It has increased from 9.49 Cr. (Mar 2024) to 21.81 Cr., marking an increase of 12.32 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 17.93 Cr.. The value appears to be declining and may need further review. It has decreased from 26.53 Cr. (Mar 2024) to 17.93 Cr., marking a decrease of 8.60 Cr..
• For Total Assets, as of Mar 2025, the value is 39.74 Cr.. The value appears strong and on an upward trend. It has increased from 36.02 Cr. (Mar 2024) to 39.74 Cr., marking an increase of 3.72 Cr..

Notably, the Reserves (25.80 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

No data available for the No. of Shareholders chart.

Key Financial Ratios

After reviewing the key financial ratios for Dhampure Speciality Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.45. This value is below the healthy minimum of 5. It has increased from 1.18 (Mar 24) to 3.45, marking an increase of 2.27.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.45. This value is below the healthy minimum of 5. It has increased from 1.18 (Mar 24) to 3.45, marking an increase of 2.27.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.86. This value is within the healthy range. It has increased from 1.60 (Mar 24) to 3.86, marking an increase of 2.26.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 40.97. It has increased from 33.62 (Mar 24) to 40.97, marking an increase of 7.35.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 40.97. It has increased from 33.62 (Mar 24) to 40.97, marking an increase of 7.35.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 47.77. It has increased from 36.85 (Mar 24) to 47.77, marking an increase of 10.92.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 4.66. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 4.66, marking an increase of 3.21.
• For PBIT / Share (Rs.), as of Mar 25, the value is 4.25. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 4.25, marking an increase of 3.22.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.51. This value is within the healthy range. It has increased from 0.95 (Mar 24) to 4.51, marking an increase of 3.56.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.45. This value is within the healthy range. It has increased from 1.18 (Mar 24) to 3.45, marking an increase of 2.27.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.45. This value is within the healthy range. It has increased from 1.18 (Mar 24) to 3.45, marking an increase of 2.27.
• For PBDIT Margin (%), as of Mar 25, the value is 9.74. This value is below the healthy minimum of 10. It has increased from 3.93 (Mar 24) to 9.74, marking an increase of 5.81.
• For PBIT Margin (%), as of Mar 25, the value is 8.89. This value is below the healthy minimum of 10. It has increased from 2.80 (Mar 24) to 8.89, marking an increase of 6.09.
• For PBT Margin (%), as of Mar 25, the value is 9.44. This value is below the healthy minimum of 10. It has increased from 2.59 (Mar 24) to 9.44, marking an increase of 6.85.
• For Net Profit Margin (%), as of Mar 25, the value is 7.23. This value is within the healthy range. It has increased from 3.20 (Mar 24) to 7.23, marking an increase of 4.03.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.23. This value is below the healthy minimum of 8. It has increased from 3.20 (Mar 24) to 7.23, marking an increase of 4.03.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.43. This value is below the healthy minimum of 15. It has increased from 3.51 (Mar 24) to 8.43, marking an increase of 4.92.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.92. This value is below the healthy minimum of 10. It has increased from 2.72 (Mar 24) to 9.92, marking an increase of 7.20.
• For Return On Assets (%), as of Mar 25, the value is 7.24. This value is within the healthy range. It has increased from 2.60 (Mar 24) to 7.24, marking an increase of 4.64.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.05. It has increased from 0.86 (Mar 24) to 1.05, marking an increase of 0.19.
• For Current Ratio (X), as of Mar 25, the value is 4.26. This value exceeds the healthy maximum of 3. It has increased from 3.55 (Mar 24) to 4.26, marking an increase of 0.71.
• For Quick Ratio (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 2. It has increased from 2.64 (Mar 24) to 3.01, marking an increase of 0.37.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.81. This value is within the healthy range. It has increased from 4.47 (Mar 24) to 4.81, marking an increase of 0.34.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 431.14. This value is within the healthy range. It has increased from 174.30 (Mar 24) to 431.14, marking an increase of 256.84.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 295.21. This value is within the healthy range. It has increased from 151.41 (Mar 24) to 295.21, marking an increase of 143.80.
• For Enterprise Value (Cr.), as of Mar 25, the value is 81.05. It has increased from 61.28 (Mar 24) to 81.05, marking an increase of 19.77.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.04. This value is within the healthy range. It has decreased from 2.10 (Mar 24) to 2.04, marking a decrease of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 20.89. This value exceeds the healthy maximum of 15. It has decreased from 53.27 (Mar 24) to 20.89, marking a decrease of 32.38.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. It has decreased from 2.17 (Mar 24) to 2.09, marking a decrease of 0.08.
• For Price / BV (X), as of Mar 25, the value is 2.43. This value is within the healthy range. It has increased from 2.37 (Mar 24) to 2.43, marking an increase of 0.06.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.09. This value is within the healthy range. It has decreased from 2.17 (Mar 24) to 2.09, marking a decrease of 0.08.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness